MINNEAPOLIS--()--Conventus Orthopaedics‚ a privately held company focused on revolutionizing treatment for peri-articular fractures, announced that it will exhibit and host a surgeon workshop at the American Society for Surgery of the Hand (ASSH) Annual Meeting Sept. 6-8, 2012 in Chicago, IL. The Conventus DRS™ Implant is designed to provide a less-invasive means for orthopaedic surgeons to treat patients with distal radius fractures, returning them to normal daily activities sooner and with less pain.
“Our participation at the ASSH annual meeting represents the first U.S. opportunity for demonstration of this innovative technology which expands possibilities for patient care. We continue to study the system in the European clinical setting and are preparing for broader regulatory approval and commercial launch”
Conventus’ novel technology and approach to treating fractures of the distal radius will be the subject of an ASSH Industry Forum on Thursday, Sept. 6, 2012 at 11:30 am in the Buckingham Room at the Hyatt Regency. The forum will feature presentations given by Sanjay Desai, M.D., Senat Krasnici, M.D., and Michael Strassmair, M.D., discussing the history of, and challenges associated with, current approaches to repairing this common fracture. They will also discuss the practical use of Conventus DRS in their clinical environments and share the outcomes of a 60 patient multi-center European clinical study. A brief hands-on workshop will follow the discussion allowing surgeons to see the process of implantation and potential benefits of a minimally invasive process.
Conventus DRS technology provides clinicians with a unique self-expanding implant that stabilizes the fractured fragments from within the bone. The surgical procedure requires only a two to three centimeter incision on the forearm and a few small incisions at the wrist. The technique reduces surgical trauma by as much as 70 percent compared to traditional plate and screw fixation techniques, and preserves soft tissues around the fracture to minimize stiffness, swelling and pain. It represents the first minimally-invasive, fragment-specific system that effectively addresses a wide range of fracture types with fixation strength equivalent to that of locking plates.
“Our participation at the ASSH annual meeting represents the first U.S. opportunity for demonstration of this innovative technology which expands possibilities for patient care. We continue to study the system in the European clinical setting and are preparing for broader regulatory approval and commercial launch,” added Paul Hindrichs, CEO of Conventus Orthopaedics.
The Conventus DRS™ is pending 510(k) clearance by FDA and is not yet cleared for commercial distribution in the United States.
About Conventus Orthopaedics
Conventus Orthopaedics, Inc. was founded in 2008 by a team of medical device professionals and physicians with the sole purpose of improving patient care by creating less invasive solutions to a broad range of challenging peri-articular fractures. Taking its name from the Latin word for coming together or union, the company is dedicated to working together with orthopedic surgeons to improve the healing process for patients that suffer peri-articular fractures.